| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background and objectives: Acute promyelocytic leukemia (APL), is a distinct subtype of acute myeloid leukemia (AML) characterized by a tendency to hemorrhage and excellent response to all-trans retinoic acid (ATRA). In this retrospective study, we aimed to determine the incidence, clinical symptoms, toxicities, and outcome of children with APL in our center.
We retrospectively reviewed the medical records of children (age <
18 years) diagnosed with APL in our pediatric hematology department
between January 2006-December 2016.
Materials and Methods
|Table 1. Pretreatment laboratory characteristics of the patients|
|Table 2. Detailed data of the patients.|